120 related articles for article (PubMed ID: 35081863)
21. Staging of oropharyngeal squamous cell carcinoma of the head and neck: Prognostic features and power of the 8th edition of the UICC staging manual.
Beltz A; Gösswein D; Zimmer S; Limburg I; Wünsch D; Gribko A; Deichelbohrer M; Hagemann J; Stauber RH; Künzel J
Eur J Surg Oncol; 2019 Jun; 45(6):1046-1053. PubMed ID: 30857877
[TBL] [Abstract][Full Text] [Related]
22. Brachytherapy and osteoradionecrosis in patients with base of tongue cancer.
Danielsson D; Hagel E; Dybeck-Udd S; Sjöström M; Kjeller G; Bengtsson M; Abtahi J; von Beckerath M; Thor A; Halle M; Friesland S; Mercke C; Westermark A; Högmo A; Munck-Wikland E
Acta Otolaryngol; 2023 Jan; 143(1):77-84. PubMed ID: 36595465
[TBL] [Abstract][Full Text] [Related]
23. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
[TBL] [Abstract][Full Text] [Related]
24. Overall survival comparison between androgen deprivation therapy (ADT) plus external beam radiation therapy (EBRT) vs ADT plus EBRT with brachytherapy boost in clinically node-positive prostate cancer.
Fischer-Valuck BW; Rao YJ; Brenneman RJ; Patel PR; Filson CP; Jani AB; Liu Y; Goyal S; Xu K; Weiss A; Kucuk O; Cimmino C; Szabo S; Rossi P; Baumann BC; Pattaras J; Hershatter B; Patel SA
Brachytherapy; 2020; 19(5):557-566. PubMed ID: 32624405
[TBL] [Abstract][Full Text] [Related]
25. Failure-free survival following brachytherapy alone or external beam irradiation alone for T1-2 prostate tumors in 2222 patients: results from a single practice.
Brachman DG; Thomas T; Hilbe J; Beyer DC
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):111-7. PubMed ID: 10924979
[TBL] [Abstract][Full Text] [Related]
26. Interstitial brachytherapy and neck dissection for Stage III squamous cell carcinoma of the mobile tongue.
Ihara N; Shibuya H; Yoshimura R; Oota S; Miura M; Watanabe H
Acta Oncol; 2005; 44(7):709-16. PubMed ID: 16227161
[TBL] [Abstract][Full Text] [Related]
27. Risk stratification of early stage oral tongue cancers based on HPV status and p16 immunoexpression.
Ramshankar V; Soundara VT; Shyamsundar V; Ramani P; Krishnamurthy A
Asian Pac J Cancer Prev; 2014; 15(19):8351-9. PubMed ID: 25339028
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of high dose rate interstitial boost brachytherapy after external beam radiation therapy in head and neck cancer--an Indian (single institutional) learning experience.
Patra NB; Goswami J; Basu S; Chatterjee K; Sarkar SK
Brachytherapy; 2009; 8(2):248-254. PubMed ID: 19230791
[TBL] [Abstract][Full Text] [Related]
29. HPV Infection and Anemia Status Stratify the Survival of Early T2 Laryngeal Squamous Cell Carcinoma.
Wang H; Zhang Z; Sun R; Lin H; Gong L; Fang M; Hu WH
J Voice; 2015 May; 29(3):356-62. PubMed ID: 25484261
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant brachytherapy removes survival disadvantage of local disease extension in stage IIIC endometrial cancer: a SEER registry analysis.
Rossi PJ; Jani AB; Horowitz IR; Johnstone PA
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):134-8. PubMed ID: 17855014
[TBL] [Abstract][Full Text] [Related]
31. Pilot study of intraoperative high dose rate brachytherapy for head and neck cancer.
Nag S; Schuller D; Pak V; Young D; Grecula J; Bauer C; Samsami N
Radiother Oncol; 1996 Nov; 41(2):125-30. PubMed ID: 9004354
[TBL] [Abstract][Full Text] [Related]
32. Small oral tongue cancers (≤ 4 cm in diameter) with clinically negative neck: from the 7th to the 8th edition of the American Joint Committee on Cancer.
Almangush A; Mäkitie AA; Mäkinen LK; Kauppila JH; Pukkila M; Hagström J; Laranne J; Soini Y; Kowalski LP; Grénman R; Haglund C; Coletta RD; Salo T; Leivo I
Virchows Arch; 2018 Oct; 473(4):481-487. PubMed ID: 30039390
[TBL] [Abstract][Full Text] [Related]
33. Management of base of tongue squamous cell carcinoma: experience with 85 patients in Taipei Veterans General Hospital.
Tseng WC; Chang SY; Chu PY; Tai SK; Wang YF; Shiao AS; Tsai TL
J Chin Med Assoc; 2011 May; 74(5):220-5. PubMed ID: 21550009
[TBL] [Abstract][Full Text] [Related]
34. The Prognosis of Radical Prostatectomy, External Beam Radiotherapy plus Brachytherapy, and External Beam Radiotherapy Alone for Patients above 70 Years with Very High-Risk Prostate Cancer: A Population-Matched Study.
Song P; Shu M; Yang L; Di X; Liu P; Liu Z; Zhou J; Dong Q
Urol Int; 2022; 106(1):11-19. PubMed ID: 34515256
[TBL] [Abstract][Full Text] [Related]
35. Clinical outcomes associated with evolving treatment modalities and radiation techniques for base-of-tongue carcinoma: thirty years of institutional experience.
Chen LA; Anker CJ; Hunt JP; Buchmann LO; Grossmann KF; Boucher K; Fang LM; Shrieve DC; Hitchcock YJ
Cancer Med; 2015 May; 4(5):651-60. PubMed ID: 25620682
[TBL] [Abstract][Full Text] [Related]
36. The value of p16 and HPV DNA in non-tonsillar, non-base of tongue oropharyngeal cancer.
Hammarstedt L; Holzhauser S; Zupancic M; Kapoulitsa F; Ursu RG; Ramqvist T; Haeggblom L; Näsman A; Dalianis T; Marklund L
Acta Otolaryngol; 2021 Jan; 141(1):89-94. PubMed ID: 32940116
[TBL] [Abstract][Full Text] [Related]
37. Brachytherapy Improves Survival in Stage III Endometrial Cancer With Cervical Involvement.
Bingham B; Orton A; Boothe D; Stoddard G; Huang YJ; Gaffney DK; Poppe MM
Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):1040-1050. PubMed ID: 28332987
[TBL] [Abstract][Full Text] [Related]
38. Does an Algorithmic Approach to Using Brachytherapy and External Beam Radiation Result in Good Function, Local Control Rates, and Low Morbidity in Patients With Extremity Soft Tissue Sarcoma?
Klein J; Ghasem A; Huntley S; Donaldson N; Keisch M; Conway S
Clin Orthop Relat Res; 2018 Mar; 476(3):634-644. PubMed ID: 29443850
[TBL] [Abstract][Full Text] [Related]
39. Phase II/III Randomized Controlled Trial of Concomitant Hyperfractionated Radiotherapy plus Cetuximab (Anti-EGFR Antibody) or Chemotherapy in Locally Advanced Head and Neck Cancer.
Al-Saleh K; El-Sherify M; Safwat R; Elbasmy A; Shete J; Hussein A; Nazeeh M; Bedair A
Gulf J Oncolog; 2019 May; 1(30):6-12. PubMed ID: 31242976
[TBL] [Abstract][Full Text] [Related]
40. Ten-year survival after High-Dose-Rate Brachytherapy combined with External Beam Radiation Therapy in high-risk prostate cancer: A comparison with the Norwegian SPCG-7 cohort.
Wedde TB; Småstuen MC; Brabrand S; Fosså SD; Kaasa S; Tafjord G; Russnes KM; Hellebust TP; Lilleby W
Radiother Oncol; 2019 Mar; 132():211-217. PubMed ID: 30389241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
